Hep B Functional Cure: Progress @12AM HST
Hepatitis B functional cure: what does it mean and how close are we to reaching it?
"New innovations are bringing us closer than ever to a functional cure for hepatitis B, which could be transformative for people living with hepatitis B. Given the new advancements in research, the World Hepatitis Alliance is hosting a webinar to provide an overview of what a functional cure is and the science driving its development. The webinar will explore the types of treatment that are currently in the clinical pipeline and what achieving a functional cure could mean for people living with hepatitis B.
Supported by Aligos Therapeutics and Virion Therapeutics”
CANCELED-Hep Free 2030: Access Workgroup @12PM HST
Letʻs get ACCESS!
Join our monthly Access workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Access workgroup focuses on projects related to immunization, testing, linkage, treatment, and provider education!
This workgroup usually meets every 3rd Tuesday. For more info on joining, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Hep Free 2030: Equity Workgroup @12PM HST
Letʻs get EQUITY!
Join our monthly Equity workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Equity workgroup focuses on projects related to language access, patient leadership, community centering, and people with lived experience.
This workgroup usually meets every 3rd Wednesday. For more info on joining, email Richard Smith: richawaii78@gmail.com
Rights and Protections @9AM HST
Rights and Protections for Harm Reduction Programs and Clients in an Increasingly Hostile Environment
“Harm reduction programs and clients face ongoing threats from law enforcement in many areas of the country. Additionally, programs and clients increasingly fear action by federal immigration officers. This webinar will provide an overview of relevant laws, including the legal rights that apply to individuals and organizations, together with suggestions for maximizing the safety of harm reduction program clients, staff, and volunteers. By attending this webinar, you will:
obtain an overview of constitutional rights in the context of harm reduction programs
learn about law governing federal drug paraphernalia and drug possession, together with a broad overview of state drug laws
obtain practical suggestions for reducing risks related to law enforcement activity, including proactive actions to reduce risk and actions to take during and after law enforcement encounters
Presenters: • Corey Davis, J.D., M.S.P.H., Director, Harm Reduction, Network for Public Health Law • Amy Lieberman, J.D., Deputy Director, Harm Reduction, Network for Public Health Law • Ashleigh Dennis, J.D., Senior Attorney, Harm Reduction, Network for Public Health Law • Michael Abrams, J.D., Senior Attorney, Harm Reduction, Network for Public Health Law • Kellen Russoniello, J.D., M.P.H., Director of Public Health, Drug Policy Alliance • Jeannette Zanipatin, J.D., Director of Policy and Advocacy, Coalition for Humane Immigration Rights”
National Viral Hep Roundtable Network @10AM
“Welcome back to the monthly NVHR Call! After a brief hiatus, we are thrilled to return with monthly webinars on the 3rd Thursday of each month at 3pm ET/12pm PT. They are open to anyone interested in viral hepatitis updates…
Please email info@nvhr.org for any questions or difficulty registering.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HepNET Leading w Lived Experience Webinar @10AM HST
“HepNET’s Leading with Lived Experience consultants are individuals trained to provide technical assistance and capacity building to the learning communities through the lens of their lived expertise with viral hepatitis.
The goals for the LLE webinar series are for our LLEs to hold conversations with folks working on different initiatives in support of viral hepatitis elimination that lead to increased quality of individual and community life and affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them.”
HEP-DART 2025 - Day 5
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
HEP-DART 2025 - Day 4
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
Hep Free 2030: Monthly Update @5PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Hep Free 2030: Monthly Update @12PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Hep Free 2030: Awareness Workgroup @11AM HST
Letʻs get AWARE!
Join our monthly Awareness workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Awareness workgroup focuses on projects related to social and traditional media, storytelling, provider and general education, and more!
This workgroup usually meets every 2nd Tuesday. For more info on joining, email Anika Martin: amartin@hhhrc.org
Prevent Cancer Community Exchange Part 2 - Viral Hep and Liver Cancer
“Overview of hepatitis A, B, C, and D viruses and their links to liver cancer and updates on evidence-based practices in screening and early detection. This session will also highlight disparities in viral hepatitis and liver cancer diagnoses and outcomes among populations at increased risk.”
HEP-DART 2025 - Day 3
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
Hep Free 2030: Advocacy Workgroup @3PM HST
Letʻs ADVOCATE!
Join our monthly Advocacy workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Advocacy workgroup focuses on projects related to legislation, policy, insurance coverage, and more!
This workgroup usually meets every 2nd Monday. For more info on joining, email Aaron Ruddick: aruddick@hhhrc.org
HEP-DART 2025 - Day 2
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
HEP-DART 2025 - Day 1
“We are pleased to announce Hep-DART 2025 will be held at the Hilton Hawaiian Village from December 7-11, 2025 in Honolulu, Hawaii.
This year will mark the 30th anniversary for the conference.
The DART series is and in-person meeting designed for vibrant scientific presentations and discussion, as well as for new investigators to meet leaders in their field, benefiting from educational feedback on their work.
The aim of HEP-DART 2025 is to assemble clinicians, researchers, basic scientists, nurses and physician assistants together to advance our knowledge of the ongoing drug development processes in the treatment of viral hepatitis (HBV, HCV, HDV, HAV and HEV), metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and hepatocellular carcinoma (HCC). This CME-accredited workshop will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community with an increased understanding of the current and future challenges in therapeutics for liver infection, disease and cancer.
We hope to see you in December!”
The Future of Access: 2025 Hawaiʻi Liver Summit @8:30AM HST
Flyer for Hawai’i Liver Summit 2025
Our annual liver summit is back on December 6, 2025!
Early bird registration is now open, with 50% discount for healthcare professionals and free registration for students, patients, and caregivers. Conference fee includes continuing education credits (if needed) as well as networking breakfast and lunch.
This year’s theme is “The Future of Access,” which will feature real stories and cases of care and treatment access for liver diseases, including:
viral hepatitis B and C;
fatty liver (MASH/MASLD);
liver cancer prevention;
patient perspectives;
artificial intelligence;
LGBTQ+ and rural communities.
We are expecting at least 100 summit attendees at the University of Hawai‘i at Mānoa John A. Burns School of Medicine (JABSOM) Auditorium for this full day CME / CE* event. This summit is intended for physicians, nurses, pharmacists, patients, caregivers, and students. For more info, please email Amy Trang, PhD at administrator@hepBtaskforce.org.
*In support of improving patient care, this activity has been planned and implemented by the Hawaiʻi Public Health Institute and the Western Region Public Health Training Center (WRPHTC). The WRPHTC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (APCE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Know Your Rights from Hep B Foundation @7AM HST
“Join us for an important and empowering Know Your Rights Webinar, featuring an experienced immigrant rights lawyer from a respected social justice organization. This session will break down what rights immigrants have and how to protect themselves and their communities. Date: Dec 3rd at 12pm ET”
Hep Free 2030: Data Workgroup @12PM HST
Letʻs get DATA!
Join our monthly Data workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Data workgroup focuses on projects related to surveillance, electronic reporting, qualitative research, and more!
This workgroup usually meets every 1st Tuesday. For more info on joining, email Myriam Saboui: myriam.saboui@doh.hawaii.gov.
World AIDS Day Hawaiʻi @5PM HST
“Join us for World AIDS Day Hawai’i 2025, a time for our community to come together in remembrance, reflection, and renewed commitment to health equity and compassion.
The evening will begin with a community reception featuring light refreshments, followed by a memorial program honoring the lives lost to HIV/AIDS and celebrating the ongoing work toward a future free of stigma and discrimination.
This year, the Hawai’i Department of Health will be honoring Kunane Dreier as the recipient of the 2025 Suzanne Richmond-Crum Award in recognition of his outstanding leadership, advocacy, and lifelong dedication to Hawaiʻi’s HIV and LGBTQIA+ communities.
Hosted by the Hawaiʻi Health & Harm Reduction Center (H3RC) in partnership with Church of the Crossroads, this annual gathering invites community members, advocates, and allies to stand together in solidarity and celebrate the power of hope, healing, and human connection.
All are welcome.
Event Details:
Date: December 1
Time: 5 – 6 pm Reception | 6 – 7:30 pm Program
Location: Church of the Crossroads (1212 University Avenue)”
Prevent Cancer Community Exchange Part 1 - Intro to NASTAD @11AM HST
“Learn about NASTAD’s services, specifically capacity building and technical assistance for viral hepatitis programs implementing prevention and surveillance activities within their jurisdictions and about NASTAD’s policy and legislative affairs, such as local, state, and national policy initiatives and how you can get involved.”
National Viral Hep Roundtable Network @10AM
“Welcome back to the monthly NVHR Call! After a brief hiatus, we are thrilled to return with monthly webinars on the 3rd Thursday of each month at 3pm ET/12pm PT. They are open to anyone interested in viral hepatitis updates…
Please email info@nvhr.org for any questions or difficulty registering.”
Triple Elimination of Hep B, HIV, Syphilis @3AM HST
World Hepatitis Testing Week: Scaling up hepatitis B within triple elimination programmes
“Triple elimination of the vertical transmission (EVT) of HIV, syphilis and hepatitis B will save thousands of lives each year. Triple elimination programmes are also key to achieving hepatitis elimination. By simplifying access to testing for pregnant women, triple elimination enables timely interventions to prevent vertical transmission – the most common cause of chronic hepatitis B. It is also a gateway to family testing, ensuring that more people living with hepatitis B are diagnosed and linked to treatment and care. As part of World Hepatitis Testing Week, the World Hepatitis Alliance is hosting a webinar to explore the critical role of triple elimination as part of comprehensive hepatitis programmes. It will discuss different approaches to scaling up EVT services and how different stakeholders can collectively work together to drive progress towards triple elimination. Supported by Abbott”
Hep Free 2030: Equity Workgroup @12PM HST
Letʻs get EQUITY!
Join our monthly Equity workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Equity workgroup focuses on projects related to language access, patient leadership, community centering, and people with lived experience.
This workgroup usually meets every 3rd Wednesday. For more info on joining, email Richard Smith: richawaii78@gmail.com
Point-of-Care Hep C Testing in Syringe Services Programs @8AM HST
“In the United States, there are an estimated 69,000 new hepatitis C (HCV) cases annually, most of which are linked to injection drug use. Historically, HCV diagnosis has required a two-step process: an antibody test followed by a confirmatory RNA test, with results often taking days or even weeks to return. In 2024, the U.S. Food and Drug Administration (FDA) approved Cepheid’s Xpert HCV test, the first point-of-care HCV RNA test, marking a major milestone for public health. This advancement allows for same-day diagnosis in under an hour, bridging critical gaps in the HCV testing and care continuum and creating new opportunities for timely linkage to care. Join us on Wednesday, November 19 at 1:00 PM ET for a webinar featuring insights from Public Health – Seattle & King County, one of the first jurisdictions in the country to implement the Xpert HCV test within a syringe services program (SSP). The study’s lead will: • Describe the protocol for conducting HCV point-of-care testing in an SSP setting • Share findings from an implementation study involving 200 people who use drugs tested for HCV • Highlight key facilitators and challenges encountered during implementation • Discuss strategies for pairing HCV point-of-care testing with linkage-to-care efforts This session will offer practical insights for health departments, harm reduction programs, and community partners interested in expanding rapid, low-barrier HCV testing models to improve diagnosis and treatment outcomes.”
Hep C RNA Point of Care in Syringe Exchanges @8AM HST
“In the United States, there are an estimated 69,000 new hepatitis C (HCV) cases annually, most of which are linked to injection drug use. Historically, HCV diagnosis has required a two-step process: an antibody test followed by a confirmatory RNA test, with results often taking days or even weeks to return. In 2024, the U.S. Food and Drug Administration (FDA) approved Cepheid’s Xpert HCV test, the first point-of-care HCV RNA test, marking a major milestone for public health. This advancement allows for same-day diagnosis in under an hour, bridging critical gaps in the HCV testing and care continuum and creating new opportunities for timely linkage to care.
Join us on Wednesday, November 19 at 1:00 PM ET for a webinar featuring insights from Public Health – Seattle & King County, one of the first jurisdictions in the country to implement the Xpert HCV test within a syringe services program (SSP). The study’s lead will:
Describe the protocol for conducting HCV point-of-care testing in an SSP setting
Share findings from an implementation study involving 200 people who use drugs tested for HCV
Highlight key facilitators and challenges encountered during implementation
Discuss strategies for pairing HCV point-of-care testing with linkage-to-care efforts
This session will offer practical insights for health departments, harm reduction programs, and community partners interested in expanding rapid, low-barrier HCV testing models to improve diagnosis and treatment outcomes.”
CANCELED - Hep Free 2030: Access Workgroup @12PM HST
Letʻs get ACCESS!
Join our monthly Access workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Access workgroup focuses on projects related to immunization, testing, linkage, treatment, and provider education!
This workgroup usually meets every 3rd Tuesday. For more info on joining, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
NEW DATE - Hep Free 2030: Advocacy Workgroup @3PM HST
Letʻs ADVOCATE!
Join our monthly Advocacy workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Advocacy workgroup focuses on projects related to legislation, policy, insurance coverage, and more!
This workgroup usually meets every 2nd Monday. For more info on joining, email Aaron Ruddick: aruddick@hhhrc.org
NEW DATE - Hep Free 2030: Monthly Update @5PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
NEW DATE - Hep Free 2030: Monthly Update @12PM HST
We wanna hear from you!
Learn and share at our monthly Zoom meeting on Hep Free 2030, the Hawai’i statewide hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Each month has two meeting options every 2nd Tuesday at 12 pm HST and 5 pm HST. For Zoom meeting info, email Thaddeus Pham: thaddeus.pham@doh.hawaii.gov
Scaling Up Hep Delta Testing @3AM HST
“Globally, it is estimated that 12 million people are living with hepatitis delta. Although hepatitis delta accounts for approximately 20% of liver disease, access to screening and treatment is largely unavailable. With exciting developments in the treatment pipeline, it is more critical than ever that we increase diagnosis rates and address the existing barriers to scaling up testing. As part of World Hepatitis Testing Week, the World Hepatitis Alliance is hosting a webinar to explore the current testing landscape for hepatitis delta, the existing recommendations and guidelines, barriers to testing, and actionable next steps for scale up. Supported by Bluejay Therapeutics”
Hep B Birth Dose Town Hall @10AM HST
“Join us for a virtual town hall to explore recent hepatitis B developments from the Advisory Committee on Immunization Practices (ACIP). This event will provide an open forum for a comprehensive Q&A session covering potential ACIP outcomes, the significance of the hepatitis B birth dose, and collaborative efforts to guarantee that every child has access to the hepatitis B vaccine.”
Hep Free 2030: Awareness Workgroup @11AM HST
Letʻs get AWARE!
Join our monthly Awareness workgroup meeting for Hep Free 2030, the Hawai’i hepatitis elimination strategy. We are looking for participation at any level from people with lived experience, patients, advocates, family members, people who use drugs, clinicians, researchers, policymakers, and more...Everyone's voice matters!
Our Awareness workgroup focuses on projects related to social and traditional media, storytelling, provider and general education, and more!
This workgroup usually meets every 2nd Tuesday. For more info on joining, email Anika Martin: amartin@hhhrc.org
Community-Led Hep Testing Workshop @6AM HST
“In the run up to World Hepatitis Testing Week, WHA is excited to host a practical workshop on community-led testing.
The workshop will be delivered three times: once each in English, French, and Spanish. By the end, participants will:
Understand the different testing available for viral hepatitis
Be aware of the cost of testing for viral hepatitis
Understand how testing works in practice
Understand the principles of community-based testing and how to implement them effectively
You can sign up below – we look forward to seeing you!”